New automated sample preparation system developed for proteomic biomarker discovery and validation

NewsGuard 100/100 Score

Key tool will aid goal of establishing an industrial-scale biomarker validation facility

A new automated sample preparation system based on Tecan's Freedom EVO- 200 liquid handling platform has been developed for proteomic biomarker discovery and validation in collaboration with the Translational Genomics Research Institute (TGen) and the Biodesign Institute at Arizona State University.

The fully automated, integrated, high-throughput system is a key tool in the research institutes' goal of establishing an industrial-scale biomarker validation facility.

The platform can prepare nearly 1,000 samples in less than 24 hours in the SISCAPA (Stable Isotope Standards with Capture by Anti-Peptide Antibody) workflow, from receiving samples in cryovials, to eluting selected peptides into 96-well plates ready for analysis by mass spectrometry.

The scientific leadership for the integrated system specification and multi-vendor competition included: Dr. Konstantinos Petritis (TGen); and Dr. Mark Holl and Dr. Deirdre Meldrum (Biodesign Institute).

"During biomarker discovery, we work with 20 to 100 samples but, once we have identified potential biomarkers, verification and clinical validation must be performed, where the challenge is to process hundreds, perhaps thousands, of samples," said Dr. Petritis, Associate Professor and Laboratory Head at TGen's Center for Proteomics.

"One of Tecan's greatest strengths was undoubtedly the ease with which it seamlessly brought everything together. Sample preparation is a critical yet extremely long, multi-stage and labor-intensive process that must be performed reproducibly. The Tecan system is a comprehensive and flexible proteomic sample preparation platform that successfully integrates and controls many different modules from a range of vendors."

Source: The Translational Genomics Research Institute

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals breakthrough in non-invasive detection of endometrial cancer